{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:28:39Z","timestamp":1786991319325,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["5K08HS024599-02"],"award-info":[{"award-number":["5K08HS024599-02"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017255","name":"Allergy Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017255","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008325","name":"Dartmouth-Hitchcock Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011824","name":"European Academy of Allergy and Clinical Immunology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016185","name":"Aimmune Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016940","name":"National Peanut Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016940","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jaip.2021.01.007","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T20:55:56Z","timestamp":1611262556000},"page":"2440-2451.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["A Cost-Effectiveness Analysis of Epinephrine Autoinjector Risk Stratification for Patients with Food Allergy\u2014One Epinephrine Autoinjector or Two?"],"prefix":"10.1016","volume":"9","author":[{"given":"Marcus","family":"Shaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Greenhawt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.01.007_bib1","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","article-title":"Anaphylaxis\u2014a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis","volume":"145","author":"Shaker","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.01.007_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.anai.2016.02.016","article-title":"The economic effect and outcome of delaying oral food challenges","volume":"116","author":"Couch","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.01.007_bib3","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1542\/peds.2009-2832","article-title":"Multicenter study of repeat epinephrine treatments for food-related anaphylaxis","volume":"125","author":"Rudders","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2021.01.007_bib5","first-page":"1","article-title":"United States Life Tables, 2015","volume":"67","author":"Arias","year":"2018","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.jaip.2021.01.007_bib6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.anai.2019.05.012","article-title":"A\u00a0primer on cost-effectiveness in the allergy clinic","volume":"123","author":"Shaker","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.01.007_bib7","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2018.6072","article-title":"QALYs in 2018\u2014advantages and concerns","volume":"319","author":"Neumann","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2021.01.007_bib8","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second Panel on Cost-Effectiveness in Health and Medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2021.01.007_bib9","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamapediatrics.2013.2376","article-title":"The economic impact of childhood food allergy in the United States","volume":"167","author":"Gupta","year":"2013","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaip.2021.01.007_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.anai.2017.05.020","article-title":"Economic evaluation of epinephrine auto-injectors for peanut allergy","volume":"119","author":"Shaker","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.01.007_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.anai.2020.01.004","article-title":"Commercial claims costs related to health care resource use associated with a diagnosis of peanut allergy","volume":"124","author":"Shaker","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.01.007_bib12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2011.03.013","article-title":"Estimating the economic burden of food-induced allergic reactions and anaphylaxis in the United States","volume":"128","author":"Patel","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.01.007_bib14","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/cea.12211","article-title":"Incidence of fatal food anaphylaxis in people with food allergy: a systematic review and meta-analysis","volume":"43","author":"Umasunthar","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.01.007_bib15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.anai.2017.06.001","article-title":"Factors associated with epinephrine administration for anaphylaxis in children before arrival to the emergency department","volume":"119","author":"Robinson","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.01.007_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaci.2010.05.018","article-title":"Trends in pediatric emergency department visits for food-induced anaphylaxis","volume":"126","author":"Rudders","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.01.007_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.anai.2018.06.035","article-title":"An economic evaluation of immediate vs non-immediate activation of emergency medical services after epinephrine use for peanut-induced anaphylaxis","volume":"122","author":"Shaker","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.01.007_bib18","doi-asserted-by":"crossref","first-page":"AB421","DOI":"10.1016\/j.jaci.2018.12.946","article-title":"The natural history of peanut and egg allergy and predictors of persistence: the HealthNuts longitudinal study, 6-year old follow-up","volume":"143","author":"Peters","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.01.007_bib19","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.anai.2011.11.010","article-title":"The natural history of persistent peanut allergy","volume":"108","author":"Neuman-Sunshine","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.01.007_bib20","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jaci.2004.08.035","article-title":"Peanut allergy: recurrence and its management","volume":"114","author":"Fleischer","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.01.007_bib21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.anai.2019.05.015","article-title":"Providing cost-effective care for food allergy","volume":"123","author":"Shaker","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.01.007_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jamapediatrics.2018.4275","article-title":"Analysis of value-based costs of undesignated school stock epinephrine policies for peanut anaphylaxis","volume":"173","author":"Shaker","year":"2019","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaip.2021.01.007_bib23","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.jaip.2019.04.029","article-title":"Cost-effectiveness of stock epinephrine autoinjectors on commercial aircraft","volume":"7","author":"Shaker","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.01.007_bib24","doi-asserted-by":"crossref","first-page":"e184728","DOI":"10.1001\/jamanetworkopen.2018.4728","article-title":"Association of fatality risk with value-based drug pricing of epinephrine autoinjectors for children with peanut allergy: a cost-effectiveness analysis","volume":"1","author":"Shaker","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2021.01.007_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpeds.2009.01.040","article-title":"Improving decision analyses: parent preferences (utility values) for pediatric health outcomes","volume":"155","author":"Carroll","year":"2009","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2021.01.007_bib29","first-page":"284","volume":"42","author":"Noimark","year":"2012","journal-title":"The use of adrenaline autoinjectors by children and teenagers, Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.01.007_bib30","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jaci.2010.02.009","article-title":"Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review","volume":"125","author":"Gonz\u00e1lez-P\u00e9rez","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.01.007_bib33","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/eurpub\/ckt010","article-title":"Health sector costs of self-reported food allergy in Europe: a patient-based cost of illness study","volume":"23","author":"Fox","year":"2013","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.jaip.2021.01.007_bib37","first-page":"418","article-title":"The impact of double-blind placebo-controlled food challenge (DBPCFC) on the socioeconomic cost of food allergy in Europe","volume":"24","author":"Cerecedo","year":"2014","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2021.01.007_bib39","author":"Shepard"},{"key":"10.1016\/j.jaip.2021.01.007_bib40","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jaci.2015.01.002","article-title":"Natural history of peanut allergy and predictors of resolution in the first 4 years of life: a population-based assessment","volume":"135","author":"Peters","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.01.007_bib41","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2019.11.027","article-title":"Global trends in anaphylaxis epidemiology and clinical implications","volume":"8","author":"Turner","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.01.007_bib43","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.jaip.2018.04.036","article-title":"The health and economic outcomes of peanut allergy management practices","volume":"6","author":"Shaker","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.01.007_bib44","doi-asserted-by":"crossref","first-page":"e1913951","DOI":"10.1001\/jamanetworkopen.2019.13951","article-title":"Simulation of health and economic benefits of extended observation of resolved anaphylaxis","volume":"2","author":"Shaker","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2021.01.007_bib45","doi-asserted-by":"crossref","first-page":"e13414","DOI":"10.2196\/13414","article-title":"Proximity-based emergency response communities for patients with allergies who are at risk of anaphylaxis: clustering analysis and scenario-based survey study","volume":"7","author":"Gaziel Yablowitz","year":"2019","journal-title":"JMIR Mhealth Uhealth"},{"key":"10.1016\/j.jaip.2021.01.007_bib46","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.jaip.2018.02.017","article-title":"A\u00a0survey of caregiver perspectives on emergency epinephrine autoinjector sharing","volume":"6","author":"Shaker","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.01.007_bib47","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.jaip.2018.01.019","article-title":"Value of a second dose of epinephrine during anaphylaxis: a patient\/caregiver survey","volume":"6","author":"Song","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.01.007_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaip.2014.07.004","article-title":"Early treatment of food-induced anaphylaxis with epinephrine is associated with a lower risk of hospitalization","volume":"3","author":"Fleming","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821000635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821000635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:28:09Z","timestamp":1761974889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219821000635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2213219821000635"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.01.007","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Cost-Effectiveness Analysis of Epinephrine Autoinjector Risk Stratification for Patients with Food Allergy\u2014One Epinephrine Autoinjector or Two?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}